跳至主要内容
临床试验/NCT07465341
NCT07465341招募中不适用

The Michigan Weight Navigation Program (MiWeigh) Study

University of Michigan1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2026年4月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
1
主要终点
Mean change in body weight in kilograms from baseline to 12 months.

研究概览

简要总结

The main purpose of this study is to determine whether people who participate in MiWeigh lose more weight than people who receive information about weight loss strategies and programs. The researchers also want to learn what parts of the program do and do not work and why. If the program is effective, the researchers want to learn how other health care systems could offer this program.

The overarching aim of the MiWeigh Study is to better help patients prevent, manage, or reverse obesity-related chronic conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Outcome assessors will be blinded.

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Body Mass index (BMI) 30 kilogram per square meter or higher
  • Diagnosed with one or more of the following weight-related conditions:
  • Type 2 Diabetes
  • Prediabetes Mellitus
  • Hyperlipidemia (HLP)
  • Hypertension (HTN)
  • Polycystic Ovary Syndrome (PCOS)
  • Obstructive Sleep Apnea (OSA) and/or
  • Metabolic dysfunction-associated steatotic liver disease (MASLD)
  • Speaks English
  • Interest in losing weight
  • Willingness to complete assessments per study protocol
  • Willing and able to use the Electronic health records patient portal to respond to messages
  • Willing to report weight weekly by text if randomized to intervention arm
  • Able to see provider virtually at certain days/times up to four times in a year

排除标准

  • ≥ 5% weight loss within the prior 12 months
  • Has had a Weight Navigation Program visit in past
  • Pregnant, planning a pregnancy, or breastfeeding in the next year
  • Ongoing participation in another weight-loss program
  • Taking an anti-obesity medication
  • Ever diagnosed with Type 1 Diabetes Mellitus (per protocol)
  • Serious uncontrolled mental health conditions as indicated (per protocol)
  • Chronic kidney disease, Stage 4 or higher
  • Alcohol dependence and opioid dependence (per protocol)
  • History of anorexia or bulimia
  • Bariatric/ gastric bypass surgery, gastric sleeve surgery, or gastric balloon procedure in last year
  • Currently enrolled in an interventional research study that is examining how a diet, program, or drug might: promote physical exercise, healthy eating habits, or weight loss; lower blood pressure; or lower blood sugar
  • Not planning to live in local area over the next year
  • Intensive cancer treatment such as bone marrow transplant, chemotherapy, radiation, or cancer related surgery (not including hormonal chemotherapy like Tamoxifen) in last six months or next 12 months
  • Other serious health issues or personal concerns that could prevent participant from completing study

研究组 & 干预措施

MiWeigh

Experimental

干预措施: MiWeigh (Behavioral)

Enhanced Usual Care

Active Comparator

干预措施: Enhanced Usual Care (EUC) (Behavioral)

结局指标

主要结局

Mean change in body weight in kilograms from baseline to 12 months.

时间窗: Baseline to 12 months

次要结局

  • Percentage of participants achieving ≥ 5% weight loss at 12 months(Baseline, 12 months)
  • Percentage of participants achieving ≥ 10% weight loss at 12 months.(Baseline, 12 months)
  • Change in waist circumference from baseline to 12 months(Baseline to 12 months)
  • Change in Body Mass Index (BMI) from baseline to 12 months(Baseline to 12 months)
  • Change from baseline to 12 months in Homeostatic Model Assessment-Insulin Resistance (HOMA-IR)(Baseline, 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dina Griauzde, Internal Medicine

Assistant Professor of Internal Medicine

University of Michigan

研究点 (1)

Loading locations...

相似试验